ID   PFKB_ECOLI              Reviewed;         309 AA.
AC   P06999; P78065; P78260;
DT   01-APR-1988, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1997, sequence version 2.
DT   15-FEB-2017, entry version 149.
DE   RecName: Full=ATP-dependent 6-phosphofructokinase isozyme 2;
DE            Short=ATP-PFK 2;
DE            Short=Phosphofructokinase 2;
DE            EC=2.7.1.11;
DE   AltName: Full=6-phosphofructokinase isozyme II;
DE   AltName: Full=Phosphohexokinase 2;
GN   Name=pfkB; OrderedLocusNames=b1723, JW5280;
OS   Escherichia coli (strain K12).
OC   Bacteria; Proteobacteria; Gammaproteobacteria; Enterobacterales;
OC   Enterobacteriaceae; Escherichia.
OX   NCBI_TaxID=83333;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=K12;
RX   PubMed=6235149; DOI=10.1016/0378-1119(84)90151-3;
RA   Daldal F.;
RT   "Nucleotide sequence of gene pfkB encoding the minor
RT   phosphofructokinase of Escherichia coli K-12.";
RL   Gene 28:337-342(1984).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=K12 / W3110 / ATCC 27325 / DSM 5911;
RX   PubMed=9097039; DOI=10.1093/dnares/3.6.363;
RA   Aiba H., Baba T., Fujita K., Hayashi K., Inada T., Isono K., Itoh T.,
RA   Kasai H., Kashimoto K., Kimura S., Kitakawa M., Kitagawa M.,
RA   Makino K., Miki T., Mizobuchi K., Mori H., Mori T., Motomura K.,
RA   Nakade S., Nakamura Y., Nashimoto H., Nishio Y., Oshima T., Saito N.,
RA   Sampei G., Seki Y., Sivasundaram S., Tagami H., Takeda J.,
RA   Takemoto K., Takeuchi Y., Wada C., Yamamoto Y., Horiuchi T.;
RT   "A 570-kb DNA sequence of the Escherichia coli K-12 genome
RT   corresponding to the 28.0-40.1 min region on the linkage map.";
RL   DNA Res. 3:363-377(1996).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=K12 / MG1655 / ATCC 47076;
RX   PubMed=9278503; DOI=10.1126/science.277.5331.1453;
RA   Blattner F.R., Plunkett G. III, Bloch C.A., Perna N.T., Burland V.,
RA   Riley M., Collado-Vides J., Glasner J.D., Rode C.K., Mayhew G.F.,
RA   Gregor J., Davis N.W., Kirkpatrick H.A., Goeden M.A., Rose D.J.,
RA   Mau B., Shao Y.;
RT   "The complete genome sequence of Escherichia coli K-12.";
RL   Science 277:1453-1462(1997).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=K12 / W3110 / ATCC 27325 / DSM 5911;
RX   PubMed=16738553; DOI=10.1038/msb4100049;
RA   Hayashi K., Morooka N., Yamamoto Y., Fujita K., Isono K., Choi S.,
RA   Ohtsubo E., Baba T., Wanner B.L., Mori H., Horiuchi T.;
RT   "Highly accurate genome sequences of Escherichia coli K-12 strains
RT   MG1655 and W3110.";
RL   Mol. Syst. Biol. 2:E1-E5(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-38.
RX   PubMed=6310120; DOI=10.1016/S0022-2836(83)80019-9;
RA   Daldal F.;
RT   "Molecular cloning of the gene for phosphofructokinase-2 of
RT   Escherichia coli and the nature of a mutation, pfkB1, causing a high
RT   level of the enzyme.";
RL   J. Mol. Biol. 168:285-305(1983).
RN   [6]
RP   IDENTIFICATION BY 2D-GEL.
RX   PubMed=9298644; DOI=10.1002/elps.1150180805;
RA   VanBogelen R.A., Abshire K.Z., Moldover B., Olson E.R.,
RA   Neidhardt F.C.;
RT   "Escherichia coli proteome analysis using the gene-protein database.";
RL   Electrophoresis 18:1243-1251(1997).
RN   [7]
RP   FUNCTION, CATALYTIC ACTIVITY, COFACTOR, MUTAGENESIS OF GLU-190, AND
RP   ENZYME REGULATION.
RX   PubMed=16866375; DOI=10.1021/bi060026o;
RA   Parducci R.E., Cabrera R., Baez M., Guixe V.;
RT   "Evidence for a catalytic Mg2+ ion and effect of phosphate on the
RT   activity of Escherichia coli phosphofructokinase-2: regulatory
RT   properties of a ribokinase family member.";
RL   Biochemistry 45:9291-9299(2006).
RN   [8]
RP   X-RAY CRYSTALLOGRAPHY (1.98 ANGSTROMS) IN COMPLEX WITH SUBSTRATE ATP
RP   AND ALLOSTERIC INHIBITOR ATP.
RX   PubMed=18762190; DOI=10.1016/j.jmb.2008.08.029;
RA   Cabrera R., Ambrosio A.L., Garratt R.C., Guixe V., Babul J.;
RT   "Crystallographic structure of phosphofructokinase-2 from Escherichia
RT   coli in complex with two ATP molecules. Implications for substrate
RT   inhibition.";
RL   J. Mol. Biol. 383:588-602(2008).
RN   [9]
RP   X-RAY CRYSTALLOGRAPHY (2.00 ANGSTROMS) IN COMPLEX WITH
RP   FRUCTOSE-6-PHOSPHATE.
RX   PubMed=21147773; DOI=10.1074/jbc.M110.163162;
RA   Cabrera R., Baez M., Pereira H.M., Caniuguir A., Garratt R.C.,
RA   Babul J.;
RT   "The crystal complex of phosphofructokinase-2 of Escherichia coli with
RT   fructose-6-phosphate: kinetic and structural analysis of the
RT   allosteric ATP inhibition.";
RL   J. Biol. Chem. 286:5774-5783(2011).
RN   [10]
RP   X-RAY CRYSTALLOGRAPHY (2.14 ANGSTROMS) IN COMPLEX WITH ADP; ATP;
RP   FRUCTOSE-1-6-DIPHOSPHATE AND FRUCTOSE-6-PHOSPHATE.
RA   Pereira H.M., Caniuguir A., Baez M., Cabrera R., Garratt R.C.,
RA   Babul J.;
RT   "Structure of E. coli PFK2 in complex with substrates and products.";
RL   Submitted (NOV-2011) to the PDB data bank.
RN   [11]
RP   X-RAY CRYSTALLOGRAPHY (2.20 ANGSTROMS) IN COMPLEX WITH ATP AND
RP   DIPHOSPHATE.
RA   Pereira H.M., Caniuguir A., Baez M., Cabrera R., Garratt R.C.,
RA   Babul J.;
RT   "Structure of E. coli PFK2 mutant Y23D.";
RL   Submitted (NOV-2011) to the PDB data bank.
RN   [12]
RP   X-RAY CRYSTALLOGRAPHY (1.70 ANGSTROMS) IN COMPLEX WITH ATP AND
RP   POTASSIUM, CATALYTIC ACTIVITY, BIOPHYSICOCHEMICAL PROPERTIES, AND
RP   ENZYME REGULATION.
RX   PubMed=23823238; DOI=10.1016/j.bpj.2013.05.028;
RA   Baez M., Cabrera R., Pereira H.M., Blanco A., Villalobos P.,
RA   Ramirez-Sarmiento C.A., Caniuguir A., Guixe V., Garratt R.C.,
RA   Babul J.;
RT   "A ribokinase family conserved monovalent cation binding site enhances
RT   the MgATP-induced inhibition in E. coli phosphofructokinase-2.";
RL   Biophys. J. 105:185-193(2013).
CC   -!- FUNCTION: Catalyzes the phosphorylation of D-fructose 6-phosphate
CC       to fructose 1,6-bisphosphate by ATP, the first committing step of
CC       glycolysis. {ECO:0000269|PubMed:16866375}.
CC   -!- CATALYTIC ACTIVITY: ATP + D-fructose 6-phosphate = ADP + D-
CC       fructose 1,6-bisphosphate. {ECO:0000269|PubMed:16866375,
CC       ECO:0000269|PubMed:23823238}.
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC         Evidence={ECO:0000269|PubMed:16866375};
CC   -!- ENZYME REGULATION: Allosterically inhibited by ATP. Allosteric
CC       ATP-binding requires the presence of the substrate ATP. Inhibited
CC       by monovalent cations with ionic radii larger than Na(+) (e.g.
CC       K(+), Cs(+)). The monovalent cations increase the affinity of the
CC       allosteric site for ATP. PFK-2 is sensitive to inhibition by
CC       fructose 1,6-diphosphate. {ECO:0000269|PubMed:16866375,
CC       ECO:0000269|PubMed:23823238}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=8 uM for ATP {ECO:0000269|PubMed:23823238};
CC         KM=6 uM for fructose 6-phosphate {ECO:0000269|PubMed:23823238};
CC   -!- PATHWAY: Carbohydrate degradation; glycolysis; D-glyceraldehyde 3-
CC       phosphate and glycerone phosphate from D-glucose: step 3/4.
CC   -!- SUBUNIT: Homodimer. {ECO:0000269|PubMed:18762190,
CC       ECO:0000269|PubMed:21147773, ECO:0000269|PubMed:23823238,
CC       ECO:0000269|Ref.10, ECO:0000269|Ref.11}.
CC   -!- INTERACTION:
CC       Self; NbExp=2; IntAct=EBI-6966085, EBI-6966085;
CC   -!- MISCELLANEOUS: Only 10% of the activity present in the wild-type
CC       strain is phosphofructokinase-2.
CC   -!- MISCELLANEOUS: This enzyme is not to be confused with 6-
CC       phosphofructo-2-kinase which is also called phosphofructokinase 2.
CC   -!- MISCELLANEOUS: E.coli has two 6-phosphofructokinases enzymes.
CC   -!- SIMILARITY: Belongs to the carbohydrate kinase PfkB family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; K02500; AAA24321.1; -; Genomic_DNA.
DR   EMBL; U00096; AAC74793.1; -; Genomic_DNA.
DR   EMBL; AP009048; BAA15500.2; -; Genomic_DNA.
DR   EMBL; K00128; AAA24320.1; -; Genomic_DNA.
DR   PIR; C64931; KIECFB.
DR   RefSeq; NP_416237.3; NC_000913.3.
DR   RefSeq; WP_000251727.1; NZ_LN832404.1.
DR   PDB; 3CQD; X-ray; 1.98 A; A/B=1-309.
DR   PDB; 3N1C; X-ray; 2.00 A; A/B/C/D=1-309.
DR   PDB; 3UMO; X-ray; 1.70 A; A/B=1-309.
DR   PDB; 3UMP; X-ray; 1.85 A; A/B=1-309.
DR   PDB; 3UQD; X-ray; 2.14 A; A/B/C/D=1-309.
DR   PDB; 3UQE; X-ray; 2.20 A; A/B=1-309.
DR   PDBsum; 3CQD; -.
DR   PDBsum; 3N1C; -.
DR   PDBsum; 3UMO; -.
DR   PDBsum; 3UMP; -.
DR   PDBsum; 3UQD; -.
DR   PDBsum; 3UQE; -.
DR   ProteinModelPortal; P06999; -.
DR   SMR; P06999; -.
DR   BioGrid; 4263076; 14.
DR   DIP; DIP-10465N; -.
DR   MINT; MINT-8178151; -.
DR   STRING; 511145.b1723; -.
DR   SWISS-2DPAGE; P06999; -.
DR   EPD; P06999; -.
DR   PaxDb; P06999; -.
DR   PRIDE; P06999; -.
DR   EnsemblBacteria; AAC74793; AAC74793; b1723.
DR   EnsemblBacteria; BAA15500; BAA15500; BAA15500.
DR   GeneID; 946230; -.
DR   KEGG; ecj:JW5280; -.
DR   KEGG; eco:b1723; -.
DR   PATRIC; 32118753; VBIEscCol129921_1794.
DR   EchoBASE; EB0694; -.
DR   EcoGene; EG10700; pfkB.
DR   eggNOG; ENOG4105DE4; Bacteria.
DR   eggNOG; COG1105; LUCA.
DR   HOGENOM; HOG000265281; -.
DR   InParanoid; P06999; -.
DR   KO; K16370; -.
DR   OMA; REYRFLM; -.
DR   PhylomeDB; P06999; -.
DR   BioCyc; EcoCyc:6PFK-2-MONOMER; -.
DR   BioCyc; MetaCyc:6PFK-2-MONOMER; -.
DR   BRENDA; 2.7.1.11; 2026.
DR   SABIO-RK; P06999; -.
DR   UniPathway; UPA00109; UER00182.
DR   EvolutionaryTrace; P06999; -.
DR   PRO; PR:P06999; -.
DR   Proteomes; UP000000318; Chromosome.
DR   Proteomes; UP000000625; Chromosome.
DR   GO; GO:0005829; C:cytosol; IDA:EcoCyc.
DR   GO; GO:0003872; F:6-phosphofructokinase activity; IDA:EcoCyc.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0000287; F:magnesium ion binding; IDA:EcoCyc.
DR   GO; GO:0009024; F:tagatose-6-phosphate kinase activity; IDA:EcoCyc.
DR   GO; GO:0006974; P:cellular response to DNA damage stimulus; IEP:EcoliWiki.
DR   GO; GO:0006096; P:glycolytic process; IMP:EcoCyc.
DR   CDD; cd01164; FruK_PfkB_like; 1.
DR   Gene3D; 3.40.1190.20; -; 1.
DR   InterPro; IPR002173; Carboh/pur_kinase_PfkB_CS.
DR   InterPro; IPR011611; PfkB_dom.
DR   InterPro; IPR029056; Ribokinase-like.
DR   InterPro; IPR017583; Tagatose/fructose_Pkinase.
DR   Pfam; PF00294; PfkB; 1.
DR   PIRSF; PIRSF000535; 1PFK/6PFK/LacC; 1.
DR   SUPFAM; SSF53613; SSF53613; 1.
DR   TIGRFAMs; TIGR03168; 1-PFK; 1.
DR   PROSITE; PS00583; PFKB_KINASES_1; 1.
DR   PROSITE; PS00584; PFKB_KINASES_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; ATP-binding; Complete proteome; Glycolysis; Kinase;
KW   Magnesium; Metal-binding; Nucleotide-binding; Reference proteome;
KW   Transferase.
FT   CHAIN         1    309       ATP-dependent 6-phosphofructokinase
FT                                isozyme 2.
FT                                /FTId=PRO_0000080083.
FT   NP_BIND     185    187       ATP. {ECO:0000269|PubMed:23823238,
FT                                ECO:0000269|Ref.10, ECO:0000269|Ref.11}.
FT   NP_BIND     224    229       ATP. {ECO:0000269|PubMed:23823238,
FT                                ECO:0000269|Ref.10, ECO:0000269|Ref.11}.
FT   REGION       12     14       Substrate binding.
FT   REGION       27     29       Substrate binding.
FT   REGION       39     43       Substrate binding.
FT   REGION       90     92       Substrate binding.
FT   REGION      187    189       Allosteric inhibitor ATP binding.
FT   ACT_SITE    256    256       {ECO:0000250}.
FT   METAL       190    190       Magnesium; catalytic. {ECO:0000305}.
FT   METAL       250    250       Potassium; via carbonyl oxygen.
FT                                {ECO:0000269|PubMed:23823238}.
FT   METAL       252    252       Potassium; via carbonyl oxygen.
FT                                {ECO:0000269|PubMed:23823238}.
FT   METAL       286    286       Potassium; via carbonyl oxygen.
FT                                {ECO:0000269|PubMed:23823238}.
FT   METAL       289    289       Potassium; via carbonyl oxygen.
FT                                {ECO:0000269|PubMed:23823238}.
FT   METAL       291    291       Potassium; via carbonyl oxygen.
FT                                {ECO:0000269|PubMed:23823238}.
FT   METAL       293    293       Potassium; via carbonyl oxygen.
FT                                {ECO:0000269|PubMed:23823238}.
FT   BINDING      27     27       Allosteric inhibitor ATP; shared with
FT                                dimeric partner.
FT                                {ECO:0000269|PubMed:18762190}.
FT   BINDING      27     27       ATP; shared with dimeric partner.
FT                                {ECO:0000269|PubMed:23823238,
FT                                ECO:0000269|Ref.10, ECO:0000269|Ref.11}.
FT   BINDING     139    139       Substrate.
FT   BINDING     248    248       ATP. {ECO:0000269|PubMed:23823238,
FT                                ECO:0000269|Ref.10, ECO:0000269|Ref.11}.
FT   BINDING     256    256       Substrate.
FT   BINDING     280    280       ATP; via carbonyl oxygen.
FT                                {ECO:0000269|PubMed:23823238,
FT                                ECO:0000269|Ref.10, ECO:0000269|Ref.11}.
FT   BINDING     284    284       ATP. {ECO:0000269|PubMed:23823238,
FT                                ECO:0000269|Ref.10, ECO:0000269|Ref.11}.
FT   MUTAGEN     190    190       E->Q: Causes a 50-fold decrease in the
FT                                kcat value and a 15-fold increment in the
FT                                apparent KM for ATP.
FT                                {ECO:0000269|PubMed:16866375}.
FT   CONFLICT     26     38       GKLRCTAPVFEPG -> ENCAVPHRCSNP (in Ref. 1;
FT                                AAA24321 and 5; AAA24320). {ECO:0000305}.
FT   CONFLICT    155    171       AAQKQGIRCIVDSSGEA -> LRKNKGSAASSTVLGQG
FT                                (in Ref. 1; AAA24321). {ECO:0000305}.
FT   CONFLICT    245    246       PV -> AL (in Ref. 1; AAA24321).
FT                                {ECO:0000305}.
FT   CONFLICT    257    258       SM -> RL (in Ref. 1; AAA24321).
FT                                {ECO:0000305}.
FT   STRAND        4      7       {ECO:0000244|PDB:3UMO}.
FT   STRAND       12     20       {ECO:0000244|PDB:3UMO}.
FT   STRAND       24     29       {ECO:0000244|PDB:3UMO}.
FT   STRAND       34     39       {ECO:0000244|PDB:3UMO}.
FT   HELIX        40     50       {ECO:0000244|PDB:3UMO}.
FT   STRAND       55     61       {ECO:0000244|PDB:3UMO}.
FT   HELIX        63     75       {ECO:0000244|PDB:3UMO}.
FT   STRAND       80     84       {ECO:0000244|PDB:3UMO}.
FT   STRAND       93     97       {ECO:0000244|PDB:3UMO}.
FT   TURN         98    100       {ECO:0000244|PDB:3UMO}.
FT   STRAND      103    107       {ECO:0000244|PDB:3UMO}.
FT   HELIX       115    125       {ECO:0000244|PDB:3UMO}.
FT   STRAND      133    138       {ECO:0000244|PDB:3UMO}.
FT   HELIX       146    158       {ECO:0000244|PDB:3UMO}.
FT   STRAND      162    166       {ECO:0000244|PDB:3UMO}.
FT   HELIX       169    175       {ECO:0000244|PDB:3UMO}.
FT   TURN        176    178       {ECO:0000244|PDB:3CQD}.
FT   STRAND      181    184       {ECO:0000244|PDB:3UMO}.
FT   HELIX       188    195       {ECO:0000244|PDB:3UMO}.
FT   HELIX       204    214       {ECO:0000244|PDB:3UMO}.
FT   STRAND      217    219       {ECO:0000244|PDB:3UMO}.
FT   STRAND      221    224       {ECO:0000244|PDB:3UMO}.
FT   HELIX       226    228       {ECO:0000244|PDB:3UMO}.
FT   STRAND      230    233       {ECO:0000244|PDB:3UMO}.
FT   STRAND      238    241       {ECO:0000244|PDB:3UMO}.
FT   HELIX       254    267       {ECO:0000244|PDB:3UMO}.
FT   HELIX       272    286       {ECO:0000244|PDB:3UMO}.
FT   STRAND      289    292       {ECO:0000244|PDB:3CQD}.
FT   HELIX       297    307       {ECO:0000244|PDB:3UMO}.
SQ   SEQUENCE   309 AA;  32456 MW;  A93BEBE0D5801309 CRC64;
     MVRIYTLTLA PSLDSATITP QIYPEGKLRC TAPVFEPGGG GINVARAIAH LGGSATAIFP
     AGGATGEHLV SLLADENVPV ATVEAKDWTR QNLHVHVEAS GEQYRFVMPG AALNEDEFRQ
     LEEQVLEIES GAILVISGSL PPGVKLEKLT QLISAAQKQG IRCIVDSSGE ALSAALAIGN
     IELVKPNQKE LSALVNRELT QPDDVRKAAQ EIVNSGKAKR VVVSLGPQGA LGVDSENCIQ
     VVPPPVKSQS TVGAGDSMVG AMTLKLAENA SLEEMVRFGV AAGSAATLNQ GTRLCSHDDT
     QKIYAYLSR
//
